High-dose psilocybin shows promise for depression treatment

Share this article Amgen grant share with artificial intelligence as a theme is 20% in Q4 2023. Grant share is based on the ratio of

Phar­varis im­me­di­ate­ly an­nounced the pric­ing of a $300 mil­lion of­fer­ing on Wednes­day af­ter dis­clos­ing pos­i­tive mid-stage da­ta on its oral drug for a rare, in­her­it­ed